Generics India's largest drugmaker Ranbaxy Laboratories (RAB: BO), which is 64% owned by Japan's Daiichi Sankyo (TYO: 4568), yesterday reported financial results for the fourth-quarter and full-year 2011, showing that consolidated sales for the quarter reached $736 million, up from $468 million in the like 2010 period Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) were 25% of sales at $188 million, compared with $53 million. 23 February 2012